EN
HI
Medicamen Biotech Chart
Medicamen Biotech Share Key Metrics
Volume
3999.00
Market Cap
327.61 CR
LTQ@LTP
86@240.55
ATP
242.54
Var Margin
100 %
Circuit Range
193.25-289.85
Delivery %
52.75 %
Value
9.70 L
ASM/GSM
No
Market Lot
1
Summary
Medicamen Biotech share price is ₹240.55 as of 24 Jun, 2026. The stock Medicamen Biotech intraday movement has stayed between ₹240.55 and ₹245.90, while on a 52-week basis,Medicamen Biotech price 52 week high is ₹447.65 & its 52 week low is ₹216.95.
In terms of trading activity, Medicamen Biotech has recorded a volume of 3999 shares, The Medicamen Biotech has a market cap of ₹13562815 CR. The stock’s Average Traded Price (ATP) stands at ₹242.54, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 86 @ ₹240.55.
Medicamen Biotech operates within a circuit range of ₹193.25 – ₹289.85, with a Value of ₹9.70 L. The Delivery Percentage for the day is 52.75%. Additionally, Medicamen Biotech currently falls under the No framework, and trades with a market lot size of 1.
Medicamen Biotech Fundamentals
P/E Ratio
33.95
P/B Ratio
1.22
Div. Yield
0.41
Sector P/E
70.34
Sector P/B
3.13
Sec. Div. Yield
0.53
Medicamen Biotech Resistance and Support
Pivot 239.87
Resistance
First Resistance
249.99
Second Resistance
258.42
Third Resistance
268.54
Support
First Support
231.44
Second Support
221.32
Third Support
212.89
Medicamen Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-27 | Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-26 | Preferential issue of shares |
| 2025-02-11 | Quarterly Results |
Medicamen Biotech News
Medicamen Biotech Ltd-$ - 531146 - Corporate Action-Board to consider Dividend
Medicamen Biotech Board has recommended a final dividend of ₹1.00 per equity share for FY26. This payout, on shares with a face value of ₹10.00, requires shareholder approval at the upcoming AGM.
May 28 2026 12:21:43
Medicamen Biotech Ltd-$ - 531146 - Compliances - Regulation 32 (1) And (3) - Statament Of Deviation & Variation Report - March 2026
Medicamen Biotech announced no deviation or variation in the utilization of funds raised through its preferential issue. The Audit Committee reviewed the fund usage, confirming that Rs. 29.30 crore out of Rs. 53.57 crore raised has been utilized as intended.
May 28 2026 12:13:32
Medicamen Biotech Management
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Independent & Non Executive Director |
Medicamen Biotech Similar Stocks
Medicamen Biotech FAQs
The Buying Price of Medicamen Biotech share is 240.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 33.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Medicamen Biotech shares is 1.22. Useful to assess the stock's value relative to its book value.
To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 70.34 & 3.13 with sector averages, along with growth rates and financial metrics.
The Market Cap of Medicamen Biotech is 327.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Medicamen Biotech share price is 447.65 & 216.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Medicamen Biotech belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
